Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koen Poesen

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 12, 2021
Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter studyPetra Steinacker, Emily Feneberg, Steffen Halbgebauer, et al.
JAMA Neurology|May 19, 2020
Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat ExpansionJoke De Vocht, Jeroen Blommaert, Martijn Devrome, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 12, 2010
Matrix-binding vascular endothelial growth factor (VEGF) isoforms guide granule cell migration in the cerebellum via VEGF receptor Flk1Carmen Ruiz de Almodovar, Cathy Coulon, Paul Antoine Salin, et al.
Nature Medicine|June 3, 2021
Publisher Correction: Altered perivascular fibroblast activity precedes ALS disease onsetAnna Månberg, Nathan Skene, Folkert Sanders, et al.
Nature Medicine|April 16, 2021
Altered perivascular fibroblast activity precedes ALS disease onsetAnna Månberg, Nathan Skene, Folkert Sanders, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 15, 2016
Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALSPatrick Oeckl, Claude Jardel, François Salachas, et al.
Cancer Cell|April 20, 2013
Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric propertiesFrançoise Bono, Frederik De Smet, Corentin Herbert, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 23, 2025
Clinical use and reporting of neurofilament quantification in neurological disorders: A global overviewConstance Delaby, Aurélie Ladang, Jose Martinez-Yriarte, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersConstance Delaby, Aurélie Ladang, Jose Yriarte, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 22, 2021
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overviewConstance Delaby, Charlotte E Teunissen, Kaj Blennow, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 12, 2021
Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter studyPetra Steinacker, Emily Feneberg, Steffen Halbgebauer, et al.
JAMA Neurology|May 19, 2020
Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat ExpansionJoke De Vocht, Jeroen Blommaert, Martijn Devrome, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 12, 2010
Matrix-binding vascular endothelial growth factor (VEGF) isoforms guide granule cell migration in the cerebellum via VEGF receptor Flk1Carmen Ruiz de Almodovar, Cathy Coulon, Paul Antoine Salin, et al.
Nature Medicine|June 3, 2021
Publisher Correction: Altered perivascular fibroblast activity precedes ALS disease onsetAnna Månberg, Nathan Skene, Folkert Sanders, et al.
Nature Medicine|April 16, 2021
Altered perivascular fibroblast activity precedes ALS disease onsetAnna Månberg, Nathan Skene, Folkert Sanders, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 15, 2016
Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALSPatrick Oeckl, Claude Jardel, François Salachas, et al.
Cancer Cell|April 20, 2013
Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric propertiesFrançoise Bono, Frederik De Smet, Corentin Herbert, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 23, 2025
Clinical use and reporting of neurofilament quantification in neurological disorders: A global overviewConstance Delaby, Aurélie Ladang, Jose Martinez-Yriarte, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersConstance Delaby, Aurélie Ladang, Jose Yriarte, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 22, 2021
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overviewConstance Delaby, Charlotte E Teunissen, Kaj Blennow, et al.
Pageof 9